Home > > Global Viscosupplementation Market Report
Viscosupplementation is a medical procedure that involves the injection of a lubricating solution into the knee joint to relieve pain caused by osteoarthritis. The market for viscosupplementation is driven by the increasing incidence of osteoarthritis, particularly in older populations, as well as the growing demand for non-surgical treatments. Opportunities in the viscosupplementation market include the development of new and improved viscosupplementation products, as well as the expansion of the market into developing countries. Trends in the viscosupplementation market include the increasing use of hyaluronic acid-based viscosupplementation products, as well as the growing adoption of minimally invasive procedures such as needle-free and single-injection viscosupplementation. Top companies in the viscosupplementation market include Sanofi, Fidia Pharma, Ferring Pharmaceuticals, Anika Therapeutics, and Seikagaku Corporation. These companies have made significant investments in research and development to improve the effectiveness of their viscosupplementation products and to expand their product portfolios. Recent developments in the viscosupplementation market include the launch of new viscosupplementation products, such as Sanofi's Hylan G-F 20, which is a next-generation hyaluronic acid-based viscosupplementation product, and Fidia Pharma's Ostenil Plus, which is a needle-free viscosupplementation product. In conclusion, the viscosupplementation market is expected to grow in the forecast period due to the increasing incidence of osteoarthritis, growing demand for non-surgical treatments and the development of new and improved viscosupplementation products by top companies.